Senior insider sale
Chief Commercial Officer at IRONWOOD PHARMACEUTICALS INC — senior position signals high conviction
$21.3K
6.32K shares
What this filing means
GASKINS TAMMI L plans to sell 6.32K shares of IRONWOOD PHARMACEUTICALS INC valued at approximately $21.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/14/2025ACC: 0002061679-25-000005
Officer· Chief Commercial Officer
Since Feb 2026
6.32K
Shares to sell
$21.3K
Approx. market value
18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements
n/a
12/11/2024
18KTotal acquired18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/11/2024 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements n/a | 18K | — |
| Total | 18K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
6.32K
Market value
$21.3K
11/17/2025
Total
Units
6.32K
Value
$21.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/17/2025 | 6.32K | $21.3K | Nasdaq | Planned |
| Total | 6.32K | $21.3K | ||